Jun Ohwada

Title: Jun Ohwada: Innovator in Pharmaceutical Chemistry

Introduction

Jun Ohwada is a prominent inventor based in Kamakura, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work primarily focuses on developing compounds that have therapeutic applications, particularly in cancer treatment.

Latest Patents

Ohwada's latest patents include innovative compounds such as aminopyrazole derivatives. The objective of this invention is to provide low-molecular-weight compounds that can inhibit Src family kinases. These compounds are represented by a general formula that includes various substituents, enhancing their pharmacological properties. Another notable patent involves pyrimidine derivatives that act as PI3K inhibitors. This drug is designed to be effective as a preventive or therapeutic agent for cancer, showcasing superior PI3K inhibitory effects along with enhanced stability and water solubility.

Career Highlights

Throughout his career, Jun Ohwada has worked with reputable companies in the pharmaceutical industry, including Basilea Pharmaceutica AG and Chugai Seiyaku Kabushiki Kaisha. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Ohwada has collaborated with notable colleagues such as Nobuo Shimma and Isao Umeda. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Jun Ohwada's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work continues to pave the way for new therapeutic options in cancer treatment.